- What is compounding?
- The Case for Office Use of Compounded Medications
- Anticipatory Compounding: An Important Part of Pharmacy Practice
- Pharmacy or Manufacturer? Size Doesn't Matter.
- Why Compounding Pharmacies Use Bulk Active Pharmaceutical Ingredients
- Why Compounding from Finished Goods Will Increase Costs
- The Law
In New National Poll, Veterinarians Report That FDA’s Proposed Guidance Will Have a Significant Negative Impact on Animal Patients.
Survey results available online.
A new nationwide poll of veterinary practices confirms that new guidance proposed by the Food & Drug Administration (FDA) would have a significant negative impact on their practices and their patients’ health if issued and enforced.
Act creates Horseracing Anti-Doping and Medication Control Authority
New authority will create a set of uniform anti-doping rules, including lists of permitted and prohibited substances and methods in line with international anti-doping standards and veterinarian ethical standards.
If finalized, GFI #256, will have serious and damaging ramifications
FDA’s new Draft Guidance for Industry, Compounding Animal Drugs from Bulk Drug Substances, would virtually eliminate this scientific best practice and force compounders to make custom pet medications from finished pills, tablets, and capsules purchased fr
Committee Demands Radical Policy Revisions
House Appropriations Committee says FDA policies go against Congressional intent
Addresses confusion over a compounding pharmacy’s “distribution” of compounded preparations
Senator David Vitter (R-LA) introduced S. 1406, the Saving Access to Compounded Medications for Special Needs Patients Act
Proposed policy lays out new rules for veterinarians
The U.S. Food and Drug Administration has made good on a decade-old promise to provide updated guidance on the regulatory complexities of compounding animal drugs from bulk substances.
A nationwide survey shows that there are unintended consequences for veterinary medicine caused by the Drug Enforcement Administration’s (DEA) efforts to address the national opioid crisis. Opioids in animal medicine are the foundation, and often the only method, of pain control and anesthesia.